A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer
| Autor: | Schneeweiss, A. *, Marmé, F., Ruiz, A., Manikhas, A.G., Bottini, A., Wolf, M., Sinn, H.-P., Mansouri, K., Kennedy, L., Bauknecht, T. |
|---|---|
| Zdroj: | In Annals of Oncology March 2011 22(3):609-617 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|